- $103.46m
- $51.96m
- $83.79m
- 27
- 47
- 43
- 33
Annual balance sheet for Pulmonx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 232 | 180 | 141 | 117 | 101 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 4.57 | 6.92 | 9.28 | 13 | 13.8 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 250 | 208 | 169 | 150 | 136 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 10.4 | 12.9 | 10.5 | 7.43 | 21.5 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 264 | 235 | 194 | 178 | 163 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 12.5 | 17.6 | 18.5 | 23.2 | 24.4 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 37.6 | 41.9 | 39.7 | 59.5 | 77 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 226 | 193 | 154 | 118 | 85.8 |
Total Liabilities & Shareholders' Equity | 264 | 235 | 194 | 178 | 163 |
Total Common Shares Outstanding |